Lyric Pharmaceutical Private Limited
About Lyric Pharmaceutical Private Limited
Data last updated:
Lyric Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC317145. Its GSTIN is 07AADCL3072H1ZM (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Adeel Khaliq and Misbah Ul Islam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 48 Top Floor Front Side Falt No .T – 7 Street No. 22 Zakir Nagar Jamia Nagar, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.93 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹33,362 (net margin 3.4%) and EBITDA of ₹33,362 (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 78% over three years and 82% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lyric Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH. No. 48 Top Floor Front Side Falt No .T – 7 Street No. 22 Zakir Nagar Jamia Nagar, New Delhi, Delhi, India – 110025
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lyric Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lyric Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lyric Pharmaceutical Private Limited, buy the company report.
Financials of Lyric Pharmaceutical Private Limited
FY 2025 filings availableLyric Pharmaceutical Private Limited reported revenue of ₹9.93 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 82%. EBITDA rose 174% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33,362 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33,362 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lyric Pharmaceutical Private Limited, buy the company report.
Board of directors of Lyric Pharmaceutical Private Limited
Lyric Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adeel Khaliq | Director | 03 May 2017 | 9 Years 6 Months | Current |
| Misbah Ul Islam | Director | 12 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Lyric Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Miranda Exports Private Limited | ₹9.93 Lakh (FY 2017) | 16.0% | Mumbai, Maharashtra, India | |||
| Jvpa Infra Con Private Limited | ₹9.93 Lakh (FY 2021) | -1.0% | Ranchi, Jharkhand, India | |||
| Diagram Vanijya Private Limited | ₹9.93 Lakh (FY 2024) | -3.0% | Sreebhumi, West Bengal, India | |||
| Shahbaz Pharma Private Limited | ₹9.93 Lakh (FY 2025) | 192.0% | Delhi, India | |||
| DRG Power Technology Private Limited | ₹9.93 Lakh (FY 2024) | -78.0% | Gurgaon, Haryana, India | |||
| Lyric Pharmaceutical Private Limitedthis company | ₹9.93 Lakh (FY 2025) | ₹33,362 | 3.4% | -3.0% | New Delhi, Delhi, India | |
| DHH Healthcare Private Limited | ₹9.93 Lakh (FY 2025) | -16.0% | Premnagar, Uttarakhand, India | |||
| Rajgharana Distributors Private Limited | ₹9.93 Lakh (FY 2018) | 12624.0% | Kolkata, West Bengal, India | |||
| Shell Specialties Private Limited | ₹9.92 Lakh (FY 2024) | 67.0% | Guwahati, Assam, India | |||
| Kalinga Interior and Paints Private Limited | ₹9.92 Lakh (FY 2025) | 66.0% | Cuttack, Odisha, India | |||
| Vallabh Traders Private Limited | ₹9.92 Lakh (FY 2018) | -84.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Lyric Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lyric Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lyric Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lyric Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCL3072H1ZM | Delhi | Active | 02 Nov 2017 |
To see the full GST registrations and return filing status of Lyric Pharmaceutical Private Limited, buy the company report.
Recent activity
Lyric Pharmaceutical Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Bilal Khan ceased to be Director on 12 Mar 2020.
Frequently asked questions
Lyric Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 May 2017 (9+ years old) and is registered under CIN U74999DL2017PTC317145.
Lyric Pharmaceutical has 2 current directors:
- Adeel Khaliq - Director
- Misbah Ul Islam - Director
The latest financial statements of Lyric Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Lyric Pharmaceutical is 07AADCL3072H1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Lyric Pharmaceutical is U74999DL2017PTC317145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lyric Pharmaceutical was incorporated on 03 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lyric Pharmaceutical by revenue are Miranda Exports Private Limited, Jvpa Infra Con Private Limited, Diagram Vanijya Private Limited, Shahbaz Pharma Private Limited, DRG Power Technology Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Bilal Khan ceased to be Director on 12 Mar 2020. Misbah Ul Islam was appointed as Director on 12 Mar 2020. Adeel Khaliq was appointed as Director on 03 May 2017.
The registered office of Lyric Pharmaceutical is at H. No. 48 Top Floor Front Side Falt No .T – 7 Street No. 22 Zakir Nagar Jamia Nagar, New Delhi, Delhi, India – 110025.
Lyric Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Lyric Pharmaceutical is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
